⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Eye Allergy Treatment Market to Surpass $5.97 Billion by 2031, Fueled by Increasing Eye Allergy Prevalence: Industry Research by The Insight Partners.
globenewswire.com
BHC
TEVA
Berman Tabacco, Sperling Kenny Nachwalter, LLC and Hilliard Shadowen LLP Announce a Class Action Settlement If You Purchased, Paid For, or Provided Reimbursement for QVAR® and/or QVAR RediHaler® Inhalers From January 1, 2015 through July 31, 2025
prnewswire.com
TEVA
Trastuzumab Biosimilars Market Analysis Report 2026: $24.48 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
AMGN
TEVA
Pharmaceutical API Manufacturing Market Research Report 2026: $347.49 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
PFE
SNY
TEVA
Analysis of the 2026 Oral Solid Dosage Contract Manufacturing Market - Scalable Pharma Solutions & Generic Demand Drive $59.05 Billion Forecast for 2030
globenewswire.com
JBL
TEVA
Teva's 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
accessnewswire.com
TEVA
Teva’s 2025 Healthy Future Report Highlights Environmental and Access to Medicines Progress, Including Meeting All Sustainability-Linked Bond Targets
globenewswire.com
TEVA
Alcoholism Treatment Market Report 2026: Revenue to Reach $36.85 Billion in 2026, Growing by $2.27 Billion YoY
globenewswire.com
ADIL
ALKS
AZN
BCO
CATX
LLY
GSK
MRK
PFE
SNY
TEVA
Medincell - UZEDY ®: Q1 2026 Net Sales Reached $63M, Up 62% Year‑on‑Year
businesswire.com
TEVA
Medincell - UZEDY ® : 63 M$ de ventes nettes au T1 2026, en hausse de 62% sur un an
businesswire.com
TEVA